Trials / Completed
CompletedNCT01714466
Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Norgine · Industry
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
A study to assess the pharmacodynamics, safety and tolerability of a PEG-based bowel cleansing solution (MOVIPREP®)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NER1006 | |
| DRUG | MOVIPREP |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-07-01
- Completion
- 2014-01-01
- First posted
- 2012-10-26
- Last updated
- 2014-11-20
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01714466. Inclusion in this directory is not an endorsement.